Episode 25: The Future of Precision Medicine with Genomenon

If it's part of your DNA, is it something that you can change? For the longest time the answer to that question has been no, but now that's not necessarily the case. Genetics is a world that is evolving at a rapid pace. And with a lot of new data coming out in the field, there is a growing need to sort that data and make it actionable. That's what this week's guest is doing. Genomenon is a genomic health IT company that connects genomic data with patient DNA in order to help diagnose and treat those with rare genetic cancers and diseases. They do this by providing their customers with tools to solve previously unsolvable mysteries. We sat down with Mike Klien, the CEO of Genomenon to explore the impact that their work is having on the health industry, and within the genetics market.


Clara Mouawad

Clara is the Content Specialist at BCC Research, where she spends her time writing blogs and white papers, designing graphics and thinking up ways BCC can take over the world...like with a podcast.

A world traveler (less so during COVID19, of course), marketing whiz and always thirsty for knowledge, Clara finds innovators in a variety of fields and asks the question that our listeners want to know: How will this industry, technology or company shape how we live and work in the future?

Episode Timeline

  • [00:29]Introducing the world of Genomics, Health IT, and Genomenon
  • [01:55]Mike's story to becoming the CEO of Genomenon
  • [03:31]The mission and work of Genomenon
  • [06:05]The role of AI in Genomenon
  • [08:08]The Mastermind Genomic Search Engine and what it does
  • [09:28]How customers have utilized the search engine
  • [12:40]The Mastermind Genomic Landscape and how Pharmaceuticals are using it
  • [14:48]Case study showcasing the impact of the Landscape in use
  • [17:13]The impact of Covid-19 on Genomenon and the industry
  • [19:19]Boots on the ground examples
  • [20:23]The future of genomics in 10-15 years